The Aporphine Alkaloid Boldine Induces Adiponectin Expression and Regulation in 3T3-L1 Cells

Overview

Journal J Med Food

Specialty Nutritional Sciences

Date 2009 Oct 28

PMID 19857072

Citations 6

Authors

Bangning Yu

Carla Cook

Nalini Santanam

Affiliations

Soon will be listed here.

Abstract

Adiponectin is an adipokine secreted by differentiated adipocytes. Clinical studies suggest a negative correlation between oxidative stress and adiponectin levels in patients with metabolic syndrome or cardiovascular disease. Natural compounds that can prevent oxidative stress mediated inhibition of adiponectin may be potentially therapeutic. Boldine, an aporphine alkaloid abundant in the medicinal plant Peumus boldus, is a powerful antioxidant. The current study demonstrates the effects of boldine on the expression of adiponectin and its regulators, CCAAT/enhancer binding protein-alpha (C/EBPalpha) and peroxisome proliferator-activated receptor (PPAR)-gamma, in 3T3-L1 cells. Differentiated 3T3-L1 adipocytes were exposed to either hydrogen peroxide (H(2)O(2)) (100 microM) or tumor necrosis factor-alpha (TNFalpha) (1 ng/mL) for 24 hours in the presence or absence of increasing concentrations of boldine (5-100 microM). Quantitative polymerase chain reaction showed that both the oxidants decreased the mRNA levels of adiponectin, PPARgamma, and C/EBPalpha to half of the control levels. Boldine, at all concentrations, counteracted the inhibitory effect of H(2)O(2) or TNFalpha and increased the expression of adiponectin and its regulators. The effect of boldine on adiponectin expression was biphasic, with the lower concentrations (5-25 microM) having a larger inductive effect compared to higher concentrations (50-100 microM). Boldine treatment alone in the absence of H(2)O(2) or TNFalpha was also able to induce adiponectin at the inductive phase of adipogenesis. Peroxisome proliferator response element-luciferase promoter transactivity analysis showed that boldine interacts with the PPAR response element and could potentially modulate PPAR responsive genes. Our results indicate that boldine is able to modulate the expression of adiponectin and its regulators in 3T3-L1 cells and has the potential to be beneficial in obesity-related cardiovascular disease.

Citing Articles

Inhibition of Gluconeogenesis by Boldine in the Perfused Liver: Therapeutical Implication for Glycemic Control.

Silva L, de Souza G, Pateis V, Ames-Sibin A, Paes Silva B, Bracht L Int J Hepatol. 2023; 2023:1283716.

PMID: 37056327 PMC: 10089784. DOI: 10.1155/2023/1283716.

Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome.

Wang F, Zhu N, Zhou F, Lin D Molecules. 2021; 26(20).

PMID: 34684698 PMC: 8540223. DOI: 10.3390/molecules26206117.

Molecular mechanism of down-regulating adipogenic transcription factors in 3T3-L1 adipocyte cells by bioactive anti-adipogenic compounds.

Guru A, Issac P, Velayutham M, Saraswathi N, Arshad A, Arockiaraj J Mol Biol Rep. 2020; 48(1):743-761.

PMID: 33275195 DOI: 10.1007/s11033-020-06036-8.

Anti-hyperglycemic and anti-hyperlipidemia effects of the alkaloid-rich extract from barks of Litsea glutinosa in ob/ob mice.

Zhang X, Jin Y, Wu Y, Zhang C, Jin D, Zheng Q Sci Rep. 2018; 8(1):12646.

PMID: 30140027 PMC: 6107583. DOI: 10.1038/s41598-018-30823-w.

Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.

Ponnala S, Gonzales J, Kapadia N, Navarro H, Harding W Bioorg Med Chem Lett. 2014; 24(7):1664-7.

PMID: 24630561 PMC: 4022183. DOI: 10.1016/j.bmcl.2014.02.066.

References

Milian L, Estelles R, Abarca B, Ballesteros R, Sanz M, Blazquez M . Reactive oxygen species (ROS) generation inhibited by aporphine and phenanthrene alkaloids semi-synthesized from natural boldine. Chem Pharm Bull (Tokyo). 2004; 52(6):696-9. DOI: 10.1248/cpb.52.696. View

Giannessi D, Maltinti M, Del Ry S . Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res. 2007; 56(6):459-67. DOI: 10.1016/j.phrs.2007.09.014. View

Stevigny C, Bailly C, Quetin-Leclercq J . Cytotoxic and antitumor potentialities of aporphinoid alkaloids. Curr Med Chem Anticancer Agents. 2005; 5(2):173-82. DOI: 10.2174/1568011053174864. View

Farmer S . Regulation of PPARgamma activity during adipogenesis. Int J Obes (Lond). 2005; 29 Suppl 1:S13-6. DOI: 10.1038/sj.ijo.0802907. View

Lanhers M, Joyeux M, Soulimani R, Fleurentin J, Sayag M, Mortier F . Hepatoprotective and anti-inflammatory effects of a traditional medicinal plant of Chile, Peumus boldus. Planta Med. 1991; 57(2):110-5. DOI: 10.1055/s-2006-960043. View

James W . The epidemiology of obesity: the size of the problem. J Intern Med. 2008; 263(4):336-52. DOI: 10.1111/j.1365-2796.2008.01922.x. View

Kita A, Yamasaki H, Kuwahara H, Moriuchi A, Fukushima K, Kobayashi M . Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem Biophys Res Commun. 2005; 331(2):484-90. DOI: 10.1016/j.bbrc.2005.03.205. View

Steffes M, Gross M, Lee D, Schreiner P, Jacobs Jr D . Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring). 2006; 14(2):319-26. DOI: 10.1038/oby.2006.41. View

Tarquini R, Lazzeri C, Laffi G, Gensini G . Adiponectin and the cardiovascular system: from risk to disease. Intern Emerg Med. 2007; 2(3):165-76. DOI: 10.1007/s11739-007-0027-9. View

10.

Hiuge A, Tenenbaum A, Maeda N, Benderly M, Kumada M, Fisman E . Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol. 2006; 27(3):635-41. DOI: 10.1161/01.ATV.0000256469.06782.d5. View

11.

Magalang U, Rajappan R, Hunter M, Kutala V, Kuppusamy P, Wewers M . Adiponectin inhibits superoxide generation by human neutrophils. Antioxid Redox Signal. 2006; 8(11-12):2179-86. DOI: 10.1089/ars.2006.8.2179. View

12.

Kubinova R, Machala M, Minksova K, Neca J, Suchy V . Chemoprotective activity of boldine: modulation of drug-metabolizing enzymes. Pharmazie. 2001; 56(3):242-3. View

13.

Gong H, Ni Y, Guo X, Fei L, Pan X, Guo M . Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol. 2004; 150(6):885-92. DOI: 10.1530/eje.0.1500885. View

14.

Hsu C, Yen G . Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J Agric Food Chem. 2007; 55(21):8404-10. DOI: 10.1021/jf071695r. View

15.

Qiao L, MacLean P, Schaack J, Orlicky D, Darimont C, Pagliassotti M . C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes. 2005; 54(6):1744-54. DOI: 10.2337/diabetes.54.6.1744. View

16.

Lu J, Huang K, Chang L, Huang Y, Chi Y, Su T . Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci. 2008; 15(5):565-76. DOI: 10.1007/s11373-008-9261-z. View

17.

Lin J, Della-Fera M, Baile C . Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes Res. 2005; 13(6):982-90. DOI: 10.1038/oby.2005.115. View

18.

Ouchi N, Walsh K . Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007; 380(1-2):24-30. PMC: 2755046. DOI: 10.1016/j.cca.2007.01.026. View

19.

Stern N, Osher E, Greenman Y . Hypoadiponectinemia as a marker of adipocyte dysfunction -- Part I: the biology of adiponectin. J Cardiometab Syndr. 2007; 2(3):174-82. DOI: 10.1111/j.1559-4564.2007.06597.x. View

20.

Fantuzzi G . Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol. 2007; 121(2):326-30. DOI: 10.1016/j.jaci.2007.10.018. View